Evidence map›Paper›PMID 38918824›Full record

ArticleAnimal microbiome2024

Gut microbiota and immune profiling of microbiota-humanised versus wildtype mouse models of hepatointestinal schistosomiasis.

K A Stark, G Rinaldi, A Costain, S Clare, C Tolley, A Almeida, C McCarthy, K Harcourt, C Brandt, T D Lawley and 7 more

Abstract read
In one paragraph

Article in Animal microbiome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

K A StarkDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
G RinaldiDepartment of Life Sciences, Aberystwyth University, Aberystwyth, UK.
A CostainLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
S ClareDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, UK.
C TolleyDepartment of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, UK.
A AlmeidaDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
C McCarthyWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
K HarcourtWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
C BrandtWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
T D LawleyWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
M BerrimanWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
A S MacDonaldLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
J E Forde-ThomasDepartment of Life Sciences, Aberystwyth University, Aberystwyth, UK.
B J HulmeDepartment of Life Sciences, Aberystwyth University, Aberystwyth, UK.
K F HoffmannDepartment of Life Sciences, Aberystwyth University, Aberystwyth, UK.
C Cantacessi *Department of Veterinary Medicine, University of Cambridge, Cambridge, UK. cc779@cam.ac.uk.
A Cortés *Departament de Farmàcia i Tecnologia Farmacèutica i Parasitologia, Universitat de València, Valencia, Spain.

Funding

Medical Research Council MR/W016184/1UK Research and Innovation MR/W013568/1Wellcome Trust
6 · The paper itself

Abstract

Mounting evidence of the occurrence of direct and indirect interactions between the human blood fluke, Schistosoma mansoni, and the gut microbiota of rodent models raises questions on the potential role(s) of the latter in the pathophysiology of hepatointestinal schistosomiasis. However, substantial differences in both the composition and function between the gut microbiota of laboratory rodents and that of humans hinders an in-depth understanding of the significance of such interactions for human schistosomiasis. Taking advantage of the availability of a human microbiota-associated mouse model (HMA), we have previously highlighted differences in infection-associated changes in gut microbiota composition between HMA and wildtype (WT) mice. To further explore the dynamics of schistosome-microbiota relationships in HMA mice, in this study we (i) characterize qualitative and quantitative changes in gut microbiota composition of a distinct line of HMA mice (D2 HMA) infected with S. mansoni prior to and following the onset of parasite egg production; (ii) profile local and systemic immune responses against the parasite in HMA as well as WT mice and (iii) assess levels of faecal inflammatory markers and occult blood as indirect measures of gut tissue damage. We show that patent S. mansoni infection is associated with reduced bacterial alpha diversity in the gut of D2 HMA mice, alongside expansion of hydrogen sulphide-producing bacteria. Similar systemic humoral responses against S. mansoni in WT and D2 HMA mice, as well as levels of faecal lipocalin and markers of alternatively activated macrophages, suggest that these are independent of baseline gut microbiota composition. Qualitative comparative analyses between faecal microbial profiles of S. mansoni-infected WT and distinct lines of HMA mice reveal that, while infection-induced alterations of the gut microbiota composition are highly dependent on the baseline flora, bile acid composition and metabolism may represent key elements of schistosome-microbiota interactions through the gut-liver axis.

Indexed as

Bacterial 16S rRNA gene sequencingBaseline gut microbiotaDysbiosisGut microbial diversityHost-parasite interactionsHuman-microbiota associated mouse modelImmune-modulationSchistosoma mansoni

Identifiers

PMID38918824
PMCPMC11201864

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.